Sex-specific functional effect of IL-12 gene polymorphisms in brain tumours

References

• Sevenich L. Turning “cold” into “hot” tumors-opportunities and challenges for radio-immunotherapy against primary and metastatic brain cancers. Front Oncol. 2019;9:1. doi: 10.3389/fonc.2019.00163.
   PubMed Web of Science ®Google Scholar
• Harter PN, Bernatz S, Scholz A, et al. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget. 2015;6(38):40836–12. doi: 10.18632/oncotarget.5696.
   PubMed Web of Science ®Google Scholar
• Berghoff AS, Fuchs E, Ricken G, et al. Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology. 2016;5(1):e1057388. doi: 10.1080/2162402X.2015.1057388.
   PubMed Web of Science ®Google Scholar
• Parakh S, Park JJ, Mendis S, et al. Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. Br J Cancer. 2017;116(12):1558–1563. doi: 10.1038/bjc.2017.142.
   PubMed Web of Science ®Google Scholar
• Di Giacomo AM, Mair MJ, Ceccarelli M, et al. Immunotherapy for brain metastases and primary brain tumors. Eur J Cancer. 2023;179:113–120. doi: 10.1016/j.ejca.2022.11.012.
   PubMed Web of Science ®Google Scholar
• Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 2007;28(1):33–38. doi: 10.1016/j.it.2006.11.002.
   PubMed Web of Science ®Google Scholar
• Gunsten S, Mikols CL, Grayson MH, et al. IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection. Immunology. 2009;126(4):500–513. doi: 10.1111/j.1365-2567.2008.02923.x.
   PubMed Web of Science ®Google Scholar
• Mirlekar B, Pylayeva-Gupta Y. IL-12 family cytokines in cancer and immunotherapy. Cancers. 2021;13(2):167. doi: 10.3390/cancers13020167.
   PubMed Web of Science ®Google Scholar
• Chiocca EA, John SY, Lukas RV, et al. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: results of a phase 1 trial. Sci Transl Med. 2019;11(505):eaaw5680. doi: 10.1126/scitranslmed.aaw5680.
   PubMed Web of Science ®Google Scholar
• Chiocca EA, Gelb AB, Chen CC, et al. Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: an open-label, multi-institutional phase I trial. Neuro Oncol. 2022;24(6):951–963. doi: 10.1093/neuonc/noab271.
   PubMed Web of Science ®Google Scholar
• Weiss T, Puca E, Silginer M, et al. Immunocytokines are a promising immunotherapeutic approach against glioblastoma. Sci Transl Med. 2020;12(564):eabb2311. doi: 10.1126/scitranslmed.abb2311.
   PubMed Web of Science ®Google Scholar
• Tao YP, Wang WL, Li SY, et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol. 2012;138(11):1891–1900. doi: 10.1007/s00432-012-1269-0.
   PubMed Web of Science ®Google Scholar
• Manolova I, Ivanova M, Vasilev G, et al. Impact of IL12B polymorphisms on genetic susceptibility and IL-12p40 and IL-23 serum levels in rheumatoid arthritis. Immunol Invest. 2020;49(1-2):1–14. doi: 10.1080/08820139.2019.1622561.
   PubMed Web of Science ®Google Scholar
• Chen H, Cheng S, Wang J, et al. Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(12):10235–10242. doi: 10.1007/s11033-012-1899-y.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang M, Tian T, et al. Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget. 2017;8(18):29795–29807. doi: 10.18632/oncotarget.16080.
   PubMedGoogle Scholar
• Zhao B, Meng LQ, Huang HN, et al. A novel functional polymorphism, 16974 a/C, in the interleukin-12-3’ untranslated region is associated with risk of glioma. DNA Cell Biol. 2009;28(7):335–341. doi: 10.1089/dna.2008.0845.
   PubMed Web of Science ®Google Scholar
• Sima X, Xu J, Li Q, et al. Gene-gene interactions between interleukin-12A and interleukin-12B with the risk of brain tumor. DNA Cell Biol. 2012;31(2):219–223. doi: 10.1089/dna.2011.1331.
   PubMed Web of Science ®Google Scholar
• Shimokawa N, Nishiyama C, Hirota T, et al. Functional analysis of a polymorphism in the promoter region of the IL-12/23p40 gene. Clin Exp Allergy. 2009;39(2):228–235. doi: 10.1111/j.1365-2222.2008.03165.x.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li B, Wang L, et al. A functional polymorphism in the promoter region of interleukin-12B increases the risk of colorectal cancer. Biomed Res Int. 2020;2020:2091781. doi: 10.1155/2020/2091781.
   PubMed Web of Science ®Google Scholar
• Miteva L, Trenova A, Slavov G, et al. IL12B gene polymorphisms have sex-specific effects in relapsing-remitting multiple sclerosis. Acta Neurol Belg. 2019;119(1):83–93. doi: 10.1007/s13760-018-01066-3.
   PubMed Web of Science ®Google Scholar
• Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet. 2001;27(2):218–221. doi: 10.1038/84872.
   PubMed Web of Science ®Google Scholar
• Stanilova S, Miteva L. Taq-I polymorphism in 3’UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun. 2005;6(4):364–366. doi: 10.1038/sj.gene.6364213.
   PubMed Web of Science ®Google Scholar
• Yilmaz V, Yentür SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine. 2005;30(4):188–194. doi: 10.1016/j.cyto.2005.01.006.
   PubMed Web of Science ®Google Scholar
• Seegers D, Zwiers A, Strober W, et al. A TaqI polymorphism in the 3’UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002;3(7):419–423. doi: 10.1038/sj.gene.6363919.
   PubMed Web of Science ®Google Scholar
• Yin M, Zhang Z, Wang Y. Anti-tumor effects of miR-34a by regulating immune cells in the tumor microenvironment. Cancer Med. 2023;12(10):11602–11610. doi: 10.1002/cam4.5826.
   PubMed Web of Science ®Google Scholar
• Salnikova LE, Belopolskaya OB, Zelinskaya NI, et al. The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor. Tumour Biol. 2013;34(5):2709–2719. doi: 10.1007/s13277-013-0823-y.
   PubMedGoogle Scholar
• Yang W, Warrington NM, Taylor SJ, et al. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Sci Transl Med. 2019;11(473):eaao5253. doi: 10.1126/scitranslmed.aao5253.
   PubMed Web of Science ®Google Scholar
• Carrano A, Juarez JJ, Incontri D, et al. Sex-specific differences in glioblastoma. Cells. 2021;10(7):1783. doi: 10.3390/cells10071783.
   PubMed Web of Science ®Google Scholar
• Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, et al. Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen. Glia. 2022;70(12):2348–2360. doi: 10.1002/glia.24255.
   PubMed Web of Science ®Google Scholar
• Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, et al. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ. 2011;2(1):7. doi: 10.1186/2042-6410-2-7.
   PubMedGoogle Scholar
• Kundu M, Roy A, Pahan K. Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ. Proc Natl Acad Sci U S A. 2017;114(43):11482–11487. doi: 10.1073/pnas.1705536114.
   PubMed Web of Science ®Google Scholar
• Kundu M, Raha S, Roy A, et al. Regression of triple-negative breast cancer in a patient-derived xenograft mouse model by monoclonal antibodies against IL-12 p40 monomer. Cells. 2022;11(2):259. doi: 10.3390/cells11020259.
   PubMed Web of Science ®Google Scholar
• Jana M, Pahan K. IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophages. Mol Immunol. 2009;46(5):773–783. doi: 10.1016/j.molimm.2008.10.033.
   PubMed Web of Science ®Google Scholar